BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sachs G, Humphries TJ. Rabeprazole: pharmacology, pharmacokinetics, and potential for drug interactions. Introduction. Aliment Pharmacol Ther. 1999;13 Suppl 3:1-2. [PMID: 10491722 DOI: 10.1046/j.1365-2036.1999.00018.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
Number Citing Articles
1 Varannes SBD, Sacher-Huvelin S, Vavasseur F, Masliah C, Rhun ML, Aygalenq P, Bonnot-Marlier S, Lequeux Y, Galmiche JP. Rabeprazole test for the diagnosis of gastro-oesophageal reflux disease: Results of a study in a primary care setting. World J Gastroenterol 2006; 12(16): 2569-2573 [PMID: 16688803 DOI: 10.3748/wjg.v12.i16.2569] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
2 Di Mario F, Aragona G, Bò ND, Ingegnoli A, Cavestro GM, Moussa AM, Iori V, Leandro G, Pilotto A, Franzè A. Use of lactoferrin for Helicobacter pylori eradication. Preliminary results. J Clin Gastroenterol. 2003;36:396-398. [PMID: 12702979 DOI: 10.1097/00004836-200305000-00006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 1.3] [Reference Citation Analysis]
3 Gibbons TE, Gold BD. The use of proton pump inhibitors in children: a comprehensive review. Paediatr Drugs 2003;5:25-40. [PMID: 12513104 DOI: 10.2165/00128072-200305010-00003] [Cited by in Crossref: 69] [Cited by in F6Publishing: 46] [Article Influence: 3.8] [Reference Citation Analysis]
4 Robinson M. Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications. Aliment Pharmacol Ther. 2004;20 Suppl 6:1-10. [PMID: 15496213 DOI: 10.1111/j.1365-2036.2004.02160.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 3.2] [Reference Citation Analysis]